1. Home
  2. GALT vs BLNK Comparison

GALT vs BLNK Comparison

Compare GALT & BLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GALT
  • BLNK
  • Stock Information
  • Founded
  • GALT 2000
  • BLNK 2009
  • Country
  • GALT United States
  • BLNK United States
  • Employees
  • GALT N/A
  • BLNK N/A
  • Industry
  • GALT Biotechnology: Pharmaceutical Preparations
  • BLNK Industrial Specialties
  • Sector
  • GALT Health Care
  • BLNK Consumer Discretionary
  • Exchange
  • GALT Nasdaq
  • BLNK Nasdaq
  • Market Cap
  • GALT 83.5M
  • BLNK 77.3M
  • IPO Year
  • GALT N/A
  • BLNK N/A
  • Fundamental
  • Price
  • GALT $2.52
  • BLNK $0.97
  • Analyst Decision
  • GALT Buy
  • BLNK Buy
  • Analyst Count
  • GALT 2
  • BLNK 8
  • Target Price
  • GALT $6.00
  • BLNK $2.61
  • AVG Volume (30 Days)
  • GALT 1.5M
  • BLNK 4.3M
  • Earning Date
  • GALT 08-12-2025
  • BLNK 08-06-2025
  • Dividend Yield
  • GALT N/A
  • BLNK N/A
  • EPS Growth
  • GALT N/A
  • BLNK N/A
  • EPS
  • GALT N/A
  • BLNK N/A
  • Revenue
  • GALT N/A
  • BLNK $109,383,000.00
  • Revenue This Year
  • GALT N/A
  • BLNK N/A
  • Revenue Next Year
  • GALT N/A
  • BLNK $31.15
  • P/E Ratio
  • GALT N/A
  • BLNK N/A
  • Revenue Growth
  • GALT N/A
  • BLNK N/A
  • 52 Week Low
  • GALT $0.73
  • BLNK $0.63
  • 52 Week High
  • GALT $3.90
  • BLNK $3.75
  • Technical
  • Relative Strength Index (RSI)
  • GALT 63.30
  • BLNK 55.64
  • Support Level
  • GALT $2.07
  • BLNK $0.88
  • Resistance Level
  • GALT $2.36
  • BLNK $1.10
  • Average True Range (ATR)
  • GALT 0.27
  • BLNK 0.08
  • MACD
  • GALT -0.01
  • BLNK 0.00
  • Stochastic Oscillator
  • GALT 61.64
  • BLNK 56.43

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.

Share on Social Networks: